Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. | 146,506 | reported | 10 Feb 2026 | tx 10+294,219−47,538 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Feb 2026 | SALE | Zentalis Pharmaceuticals, Inc. | 29,951 | 2.43 USD | |
| 10 Feb 2026 | SALE | Zentalis Pharmaceuticals, Inc. | 6,894 | 2.42 USD | |
| 09 Feb 2026 | SALE | Zentalis Pharmaceuticals, Inc. | 3,379 | 2.39 USD | |
| 03 Feb 2026 | SALE | Zentalis Pharmaceuticals, Inc. | 556 | 2.52 USD | |
| 02 Feb 2026 | SALE | Zentalis Pharmaceuticals, Inc. | 2,540 | 2.55 USD | |
| 08 Jan 2026 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 100,000 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 158,586 | 0.00 USD | |
| 03 Feb 2025 | SALE | Zentalis Pharmaceuticals, Inc. | 2,615 | 1.71 USD | |
| 03 Feb 2025 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 35,633 | 0.00 USD | deriv |
| 04 Oct 2024 | SALE | Zentalis Pharmaceuticals, Inc. | 1,603 | 3.18 USD |